$2.80
At close: Feb 28, 10:41 AM EDT
Comments
Loading...
WuXi Biologics (Cayman) Analyst Ratings and Price Targets | OTC:WXIBF | Benzinga
WuXi Biologics (Cayman) Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for WuXi Biologics (Cayman) Corp from these most-recent analyst ratings.
Analyst Ratings for WuXi Biologics (Cayman)
Data brought to you by Benzinga APIs
FAQ
What is the target price for WuXi Biologics (Cayman) (WXIBF) stock?
There is no price target for WuXi Biologics (Cayman)
What is the most recent analyst rating for WuXi Biologics (Cayman) (WXIBF)?
There is no analyst for WuXi Biologics (Cayman)
When was the last upgrade for WuXi Biologics (Cayman) (WXIBF)?
There is no last upgrade for WuXi Biologics (Cayman)
When was the last downgrade for WuXi Biologics (Cayman) (WXIBF)?
There is no last downgrade for WuXi Biologics (Cayman).
When is the next analyst rating going to be posted or updated for WuXi Biologics (Cayman) (WXIBF)?
There is no next analyst rating for WuXi Biologics (Cayman).
Is the Analyst Rating WuXi Biologics (Cayman) (WXIBF) correct?
There is no next analyst rating for WuXi Biologics (Cayman).
Browse analyst ratings and price targets on all stocks.